As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a ...

Hepatitis A infection requires understanding symptoms, prevention strategies, and recovery management for effective treatment and lifelong immunity development.

Medically reviewed by Qin Rao, MD Hepatitis A is a temporary liver infection caused by the hepatitis A virus. Symptoms include diarrhea, dark urine, fatigue, fever, nausea, vomiting, pain, and ...

We found a high but decreasing incidence rate of hepatitis C in Georgia among people tested more than once. The country should scale up preventive interventions to reduce incidence further and reach ...

A research team from Bochum and Hannover shows that the hepatitis E virus also attacks organs other than the liver.

Kennedy Jr. and the members of his newly appointed vaccine panel are casting doubt on the hepatitis B vaccine and the ...

The hepatitis E virus (HEV) causes severe liver inflammation. A research team from Ruhr University Bochum, Germany, and ...

Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV), which can present either as an acute (short-term) or chronic (long-term) illness ...

Mavyret marks the first and only direct-acting antiviral approved to treat both acute and chronic hepatitis C virus infections in adults and children aged three years and older, without cirrhosis or ...

In 2019, the FDA approved Mavyret to shorten the once-daily treatment duration from 12 to 8 weeks in treatment-naïve, compensated cirrhotic, chronic hepatitis C (HCV) patients across all ...

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data.